A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)

Clinical trial NCT00543920 · COMPLETED

Trial details

NCT number: NCT00543920
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anxiety Disorders

Start date: 2002-08-01
Primary completion: 2003-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.